FDA
approval
· 2025-02-21
FDA Approved: CARDENE IV — Supplemental Application (Baxter Healthcare Corporation)
Summary
The FDA approved a supplemental application for Cardene IV (nicardipine hydrochloride) from Baxter Healthcare Corporation, confirming the intravenous formulatio…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for CARDENE IV (NICARDIPINE HYDROCHLORIDE)